Increasing cases of CKD diseases are expected to contribute to the growth of the Bioimpedance Devices Market throughout the forecast period.
Request Sample Copy of Report @
https://www.futuremarketinsights.com/reports/sample/rep-gb-5563
| Attribute | Details |
| Bioimpedance Devices Market Estimated Size 2022 | US$ 492.1 Mn |
| Bioimpedance Devices Market Value-based CAGR (2022-2028) | ~6.4% |
| Bioimpedance Devices Market Size in Projected 2028 | US$ 715.1 Mn |
A medical condition known as chronic kidney disease (CKD) is characterized by a progressive decline in kidney function over time.
According to the National Kidney Foundation, Inc., millions of Americans are at high risk of developing CKD, and 30 million of them have chronic kidney disease.
For studying kidney function, the Glomerular Filtration Rate (GFR) is the best overall index.
In non-diabetic patients with chronic kidney disease, bioelectrical impedance, also known as bioimpedance, is used to more accurately estimate the glomerular filtration rate as well as muscle mass.
Appendicular lean mass can also be measured using bioelectrical impedance analysis (BIA) (ALM).
Demographic variables can be used to compare how well these equations perform at estimating renal inulin clearance (GFR INU), and they can also be used to modify diets for the treatment of renal disease (MDRD).
The sales of portable and hand-held Bioimpedance devices have significantly increased in recent years thanks to widely used online marketing channels.
For instance, a research study estimated that in 2015, about 70% of Americans relied on online shopping portals to make purchases of various goods.
To ensure better access to their devices and boost sales, vendors in the bioimpedance device market are concentrating on promotional tactics and online marketing.
Vendors can reduce operational and distribution costs by using the devices they offer online.
Vendors can also provide information about the devices in their portfolio through the online marketing channel and gain access to both local and international markets.
Additionally, these online marketing websites offer a huge variety of premium Bioimpedance systems for less money.
The majority of companies that produce bioimpedance devices are concentrating on creating portable, cost-effective products.
Due to their many benefits, portable bioimpedance equipment is becoming more and more popular. For example, Bioimpedance Devices are noninvasive, practical, secure, and simple to use.
Since these gadgets are lightweight, they are frequently used in home healthcare settings to keep an eye on everyone in the family’s health.
The sum of these factors is anticipated to fuel demand for portable Bioimpedance devices over the course of the forecast period.
Feel free to ask your queries @
https://www.futuremarketinsights.com/ask-question/rep-gb-5563
People are also overwhelmingly choosing portable/hand-held bioimpedance devices for travel.
For instance, the demand for the hand-held Bioimpedance device ImpediMed SFB7 is rising due to its portability.
Over the course of the forecast period, technological developments to improve the quality of Bioimpedance devices and boost patient compliance are also anticipated to propel the market’s expansion.
Because they can measure impedances at various frequencies, multiple-frequency bioimpedance devices are highly preferred.
This offers a more accurate and effective estimation of water within and outside of cells as well as total body water.
Single-frequency bioimpedance devices can determine total body water and fat-free mass, but they are unable to determine intracellular and extracellular body water.
Over the course of the forecast period, multiple-frequency Bioimpedance devices are anticipated to gain popularity and raise consumer awareness.
The market for bioimpedance devices has been divided into segments by product type, modality, and end user by FMI.
Single-frequency and multiple-frequency bioimpedance devices make up the two product categories in the bioimpedance devices market.
The market for bioimpedance devices is divided into two categories based on modality: wired and wireless bioimpedance devices.
The report tracks some of the key companies operating in the Bioimpedance Devices market, including General Electric Company, Omron Corporation, Fresenius Medical Care, ImpediMed Limited, SELVAS AI Inc., Tanita Corporation, RJL Systems, Inc., Maltron International Ltd., Bodystat Limited and SMT Medical GmbH.
Bioimpedance Devices Market by Category Product Type:
- Single-frequency Bioimpedance Devices
- Multiple-frequency Bioimpedance Devices
Modality:
- Wired Bioimpedance Devices
- Wireless Bioimpedance Devices
Request a Complete TOC of this Report with figures @
https://www.futuremarketinsights.com/toc/rep-gb-5563
End Users
- Hospitals
- Specialty Clinics
- Rehabilitation Centers
- Others
About Future Market Insights (FMI)
Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.
Contact:
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs